SO
RVLP

STRS Ohio’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

STRS Ohio’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,600
Closed -$14K – 2317
2020
Q3 		$14K Hold
2,600
– – ﹤0.01% 2116
2020
Q2 		$17K Hold
2,600
– – ﹤0.01% 2062
2020
Q1 		$8K Hold
2,600
– – ﹤0.01% 1952
2019
Q4 		$18K Hold
2,600
– – ﹤0.01% 1985
2019
Q3 		$9K Hold
2,600
– – ﹤0.01% 2028
2019
Q2 		$9K Hold
2,600
– – ﹤0.01% 2079
2019
Q1 		$9K Hold
2,600
– – ﹤0.01% 2013
2018
Q4 		$20K Buy
+2,600
New +$20.8K ﹤0.01% 1993

Other funds holding RVLP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

STRS Ohio's RVLP Position: Q4 2020 in Review

STRS Ohio sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2020, closing a stake of 2,600 shares — an estimated $14K sold.

STRS Ohio first reported a position in RVLP in Q4 2018 and held it in 8 quarters. The position peaked at $20K in Q4 2018. 60 funds tracked by Wall St. Rank hold RVLP as of Q4 2020.

  • STRS Ohio reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 2,600 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2020, an estimated $14K.
  • STRS Ohio first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 8 quarters.
  • STRS Ohio's RVL Pharmaceuticals plc Ordinary Shares position peaked at $20K in Q4 2018.
  • 60 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.